Cosmetic Outcome in Patients Receiving an Interstitial Implant as Part of Breast-Conservation Therapy1
Bradley A. Kramer, MD,
Douglas W. Arthur, MD,
Kenneth Ulin, PhD,
Rupert K. A. Schmidt-Ullrich, MD,
Robert D. Zwicker, PhD and
David E. Wazer, MD
1 From the Department of Radiation Oncology, New England Medical Center, Tufts University School of Medicine, Boston, Mass (B.A.K., K.U., D.E.W.), and the Department of Radiation Oncology, Massey Cancer Center, Medical College of Virginia of Virginia Commonwealth University, Richmond (D.W.A., R.K.A.S.U., R.D.Z.). From the 1998 RSNA scientific assembly. Received August 26, 1998; revision requested October 22; revision received January 14, 1999; accepted February 23. Address reprint requests to B.A.K., Department of Radiation Oncology, Midwestern Regional Medical Center, 2520 Elisha Ave, Zion, IL 60099.

View larger version (10K):
[in a new window]
|
Figure 1. Graph shows the probability of excellent cosmesis versus the dose homogeneity index (DHI).
|
|
Copyright © 1999 by the Radiological Society of North America.